HeartSciences (HSCS) Amortization of Deferred Charges (2022 - 2026)
HeartSciences' (HSCS) quarterly Amortization of Deferred Charges came in at $100833.0 in Q2 2026, down 8.29% YoY from $109950.0 in Q2 2025, and down 61.79% on a QoQ basis from $263880.0 in Q4 2025.
HeartSciences (HSCS) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has 5 years of Amortization of Deferred Charges data on file, last reported at $100833.0 in Q2 2026.
- Quarterly Amortization of Deferred Charges fell 8.29% year-over-year to $100833.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $584613.0 (up 104.5% YoY) and the FY2026 annual result came in at $495950.0, up 73.49% from the prior year.
- Amortization of Deferred Charges declined to $100833.0 in Q2 2026, from $263880.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $263880.0 in Q4 2025 to a low of $19498.0 in Q3 2023.
- A 5-year average of $84263.9 and a median of $63378.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges sank 68.23% — and 2025, when it soared 492.78%.
- Tracing HSCS's Amortization of Deferred Charges over 5 years: stood at $61381.0 in 2022, then increased by 3.25% to $63378.0 in 2023, then fell by 29.76% to $44516.0 in 2024, then soared by 492.78% to $263880.0 in 2025, then tumbled by 61.79% to $100833.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $100833.0 (Q2 2026), $263880.0 (Q4 2025), and $109950.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | HeartSciences | 6.51 Mn | 4.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 100,833.00 |
| Apr 30, 2026 | 100,833.00 |
| Oct 31, 2025 | 263,880.00 |
| Oct 31, 2025 | 263,880.00 |
| Jul 31, 2025 | 109,950.00 |
| Jul 31, 2025 | 109,950.00 |
| Apr 30, 2025 | 109,950.00 |
| Apr 30, 2025 | 109,950.00 |
| Jan 31, 2025 | 109,950.00 |
| Jan 31, 2025 | 109,950.00 |
| Oct 31, 2024 | 44,516.00 |
| Oct 31, 2024 | 44,516.00 |
| Jul 31, 2024 | 21,454.00 |
| Jul 31, 2024 | 21,454.00 |
| Jan 31, 2024 | 20,719.00 |
| Jan 31, 2024 | 20,719.00 |
| Oct 31, 2023 | 63,378.00 |
| Oct 31, 2023 | 63,378.00 |
| Jul 31, 2023 | 19,498.00 |
| Jul 31, 2023 | 19,498.00 |